ORIGINAL RESEARCH
Published on 05 Nov 2025
Sintilimab plus a bevacizumab biosimilar (IBI305) in advanced HCC with Child-Pugh A/B liver function: a real-world multicenter retrospective study
doi 10.3389/fonc.2025.1681663
- 567 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
5,339
Total downloads
27k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 31 Oct 2025
Case Report: A neoantigen-targeting peptide vaccine combined with checkpoint inhibition induces tumor regression and long-term remission in a pediatric patient with metastatic hepatocellular carcinoma
doi 10.3389/fimmu.2025.1674663
- 870 views
REVIEW
Published on 30 Oct 2025
Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation
doi 10.3389/fimmu.2025.1702860
- 484 views
ORIGINAL RESEARCH
Accepted on 09 Oct 2025
Economic Evaluation of Anlotinib Plus Penpulimab Versus Sorafenib as First-Line Therapy for Unresectable Hepatocellular Carcinoma in China
- 270 views
ORIGINAL RESEARCH
Published on 17 Sep 2025
Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1614702
- 1,639 views
ORIGINAL RESEARCH
Published on 11 Sep 2025
Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway
doi 10.3389/fimmu.2025.1612318
- 1,163 views
ORIGINAL RESEARCH
Published on 01 Sep 2025
Efficacy and safety of DEB-TACE combined with transarterial TQB2450 infusion and oral Anlotinib as first-line treatment in advanced hepatocellular carcinoma: a single-arm phase II study
doi 10.3389/fimmu.2025.1667785
- 1,349 views
ORIGINAL RESEARCH
Published on 27 Aug 2025
ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia
doi 10.3389/fonc.2025.1589053
- 2,038 views
CASE REPORT
Published on 15 Aug 2025
Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature
doi 10.3389/fonc.2025.1576892
- 1,558 views
SYSTEMATIC REVIEW
Published on 24 Jul 2025
Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1586914
- 2,384 views
ORIGINAL RESEARCH
Published on 23 Jun 2025
The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma
doi 10.3389/fimmu.2025.1585956
- 1,431 views
ORIGINAL RESEARCH
Published on 12 Jun 2025
Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody
doi 10.3389/fimmu.2025.1599764
- 2,858 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: